Safety and Efficacy of Inebilizumab as Treatment for Newly Presenting Neuromyelitis Optica Spectrum Disorder (P15-1.004)

Journal article

Peer reviewed

John Lindsey, Evanthia Bernitsas, Dewei She, Eliezer Katz and Bruce Cree

Neurology, Vol.98(18_supplement)

05/03/2022

Abstract

Abstract only

1 Record Views

Title: Safety and Efficacy of Inebilizumab as Treatment for Newly Presenting Neuromyelitis Optica Spectrum Disorder (P15-1.004)
Creators: John Lindsey - The University of Texas Health Science Center at Houston
Evanthia Bernitsas - Wayne State University
Dewei She - Horizon Therapeutics (United Kingdom)
Eliezer Katz - Horizon Therapeutics (United Kingdom)
Bruce Cree - Center for Neurosciences
Publication Details: Neurology, Vol.98(18_supplement)
Identifiers: 991006150048602656
Academic Unit: Neurology
Language: English
Resource Type: Journal article